NS-304 Placebo ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
70	広範脊柱管狭窄症	1
88	慢性血栓塞栓性肺高血圧症	1

70. 広範脊柱管狭窄症

臨床試験数 : 96 / 薬物数 : 203 - (DrugBank : 60) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 89

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-183866	02/2/2018	15/02/2018	Placebo-controlled, double-blind, exploratory study of NS-304 in lumbar spinal stenosis (LSS) patien ...	Placebo-controlled, double-blind, exploratory study of NS-304 in lumbar spinal stenosis (LSS) patien ...	LSS	Intervention name : NS-304 INN of the intervention : Selexipag Dosage And administration of the interv ...	Nippon Shinyaku Co., Ltd.	NULL	complete	40	79	BOTH	120	Phase 2	Japan

臨床試験数 : 159 / 薬物数 : 118 - (DrugBank : 23) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 53

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-163279	10/6/2016	01/06/2016	A confirmatory (phase III) study of the efficacy and safety of NS-304 (selexipag) in patients with c ...	A confirmatory (phase III) study of the efficacy and safety of NS-304 (selexipag) in patients with c ...	Chronic thromboembolic pulmonary hypertension (CTEPH)	Intervention name : NS-304 INN of the intervention : Selexipag Dosage And administration of the interv ...	Nippon Shinyaku Co., Ltd.	NULL	complete	20	85	BOTH	72	Phase 3	Japan